Search for: "Sciele Pharma, Inc."
Results 1 - 4 of 4
Sorted by Relevance | Sort by Date
RSS Subscribe:  20 results  |  100 results
18 Sep, 2008 1:36 pm
... in children ages 3 to 18 with cerebral palsy and other neurological disorders. A new drug known as glycopyrrolate, made by Sciele Pharma Inc., has shown promise in a recent clinical trial. Patients who received the drug during a 24-week trial drooled significantly less ... was seen as early as eight weeks after the drug treatment began. The drug is not yet approved by the Food and Drug Administration. Sciele is expected to submit a completed New Drug Application to the agency by the end of the year.
Tags: Palsy, Cerebral
Cerebral Palsy Law Blog - http://www.cerebralpalsylawblog.com/
24 Oct, 2007 12:46 pm by Phil
The following excerpt comes from a Mylan press release issued yesterday, October 23, 2007: Mylan Inc. (NYSE: MYL) today announced that it and its subsidiary Mylan Pharmaceuticals Inc. have entered into a patent license and settlement ... to our portfolio." In additional news related to Mylan, Sepracor filed suit against Dr Reddy Laboratories Ltd and Mylan to block generic versions of the allergy pill Clarinex until 2014 and Sciele Pharma files suit against Mylan over patent for Sular medicine.
Tags: Payments, Reverse
Philip Brooks' Patent Infringement Updates - http://infringement.blogs.com/philip_brooks_patent_infr/
23 Dec, 2007 8:00 pm
... therapy Lyrica to Royalty Pharma for $700 million: (IP Law360), Neopogen (Filgrastim) - Sloan-Kettering Institute for Cancer Research sues Amgen Inc. for allegedly evading royalty ... (ethinylestradiol) - Barr sues to block generic Seasonale: (IP Law360), Sular (Nisoldipine) - Sciele sues Mylan over ANDA filing: (Generic Pharmaceuticals & IP) Tarka ... IP Law360), Claim constructions adopted in catheter patent suit between Medtronic Inc and Boston Scientific Corp: (IP Law360), Broadcom gets over $9m ...
IP Thinktank - http://duncanbucknell.com/blog
2 Aug, 2008 12:54 am
... on: (Law360), US: JEC holds hearing on drug pricing; GPhA lobbies for follow-on biologics pathway: (Patent Docs) Pharma & Biotech - Products Aciphex (Rabeprazole) - US: Eisai patent survives obviousness claim post-KSR: Eisai v Dr ... Astra on Teva's claim of inequitable conduct in Seroquel patent prosecution: (Patent Appeal Tracer), Sular (Nisoldipine) - US: Sciele shares fall as Mylan launches generic Sular: (GenericsWeb), Symbicort (Formterol fumarate dehydrate and budesonide) - US: Synergy ...
IP Thinktank - http://duncanbucknell.com/blog
         
Add to your RSS Reader Add to your Google Add to your My Yahoo Add to your My MSN Add to your My AOL Add to your Feedster Add to your Newsgator Add to your Bloglines Add to your NewsBurst Add to your Rojo Add to your Pluck